Skip to content

NKTR · Nektar Therapeutics

Healthcare

☆ Add to watchlist

Updated Oct 29 · 14 feeds behind: Congress trades, 22 days, and 13 more · Every feed →

On this page

The market view

Price chart

The interactive NKTR chart (by TradingView) loads here.

Our take

3 rules fired on NKTR

In short: none of these rules has solid or some evidence yet, so they show no clear lean on NKTR.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for NKTR, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on NKTR, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of NKTR. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Oct 11, 2026–Nov 7, 2026 · UTC dates · today is excluded

Insider purchases

Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored.

Latest 28 days
0
Earlier median
0
Earlier range
0–0
Distinct filers per 28 daysScale: 0–1
Nov 9, 2025Nov 7, 2026
Earlier periodsLatest 28 daysEarlier median 0Limited or missing history

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 17, 2026. Newest disclosure across this feed: Oct 27, 2026.

Earlier periods in the comparison: 4. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Nov 9, 2025–Dec 6, 2025—Unavailable
Dec 7, 2025–Jan 3, 2026—Unavailable
Jan 4, 2026–Jan 31, 2026—Unavailable
Feb 1, 2026–Feb 28, 2026—Unavailable
Mar 1, 2026–Mar 28, 2026—Unavailable
Mar 29, 2026–Apr 25, 2026—Unavailable
Apr 26, 2026–May 23, 2026—Unavailable
May 24, 2026–Jun 20, 20260Partial; excluded
Jun 21, 2026–Jul 18, 20260Within stored history
Jul 19, 2026–Aug 15, 20260Within stored history
Aug 16, 2026–Sep 12, 20260Within stored history
Sep 13, 2026–Oct 10, 20260Within stored history
Oct 11, 2026–Nov 7, 2026Latest period0Partial; excluded
Insider sales · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: 0.5; range: 0–2.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Nov 9, 2025–Dec 6, 2025—Unavailable
Dec 7, 2025–Jan 3, 2026—Unavailable
Jan 4, 2026–Jan 31, 2026—Unavailable
Feb 1, 2026–Feb 28, 2026—Unavailable
Mar 1, 2026–Mar 28, 2026—Unavailable
Mar 29, 2026–Apr 25, 2026—Unavailable
Apr 26, 2026–May 23, 2026—Unavailable
May 24, 2026–Jun 20, 20262Partial; excluded
Jun 21, 2026–Jul 18, 20261Within stored history
Jul 19, 2026–Aug 15, 20260Within stored history
Aug 16, 2026–Sep 12, 20262Within stored history
Sep 13, 2026–Oct 10, 20260Within stored history
Oct 11, 2026–Nov 7, 2026Latest period0Partial; excluded
Congress purchases · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Nov 9, 2025–Dec 6, 2025—Unavailable
Dec 7, 2025–Jan 3, 2026—Unavailable
Jan 4, 2026–Jan 31, 2026—Unavailable
Feb 1, 2026–Feb 28, 2026—Unavailable
Mar 1, 2026–Mar 28, 2026—Unavailable
Mar 29, 2026–Apr 25, 2026—Unavailable
Apr 26, 2026–May 23, 2026—Unavailable
May 24, 2026–Jun 20, 2026—Unavailable
Jun 21, 2026–Jul 18, 2026—Unavailable
Jul 19, 2026–Aug 15, 2026—Unavailable
Aug 16, 2026–Sep 12, 2026—Unavailable
Sep 13, 2026–Oct 10, 2026—Unavailable
Oct 11, 2026–Nov 7, 2026Latest period—Unavailable
Congress sales · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Nov 9, 2025–Dec 6, 2025—Unavailable
Dec 7, 2025–Jan 3, 2026—Unavailable
Jan 4, 2026–Jan 31, 2026—Unavailable
Feb 1, 2026–Feb 28, 2026—Unavailable
Mar 1, 2026–Mar 28, 2026—Unavailable
Mar 29, 2026–Apr 25, 2026—Unavailable
Apr 26, 2026–May 23, 2026—Unavailable
May 24, 2026–Jun 20, 2026—Unavailable
Jun 21, 2026–Jul 18, 2026—Unavailable
Jul 19, 2026–Aug 15, 2026—Unavailable
Aug 16, 2026–Sep 12, 2026—Unavailable
Sep 13, 2026–Oct 10, 2026—Unavailable
Oct 11, 2026–Nov 7, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 27, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

FDA & trials

Owners & lobbying

All 22 records in this snapshot
  1. Filed
  2. Filed
  3. Filed
  4. Record date
  5. Filed
  6. Filed
  7. Disclosed
    Howard W Robin · Sale

    Transaction dated Aug 18, 2026

  8. Disclosed
    Jonathan Zalevsky · Sale

    Transaction dated Aug 18, 2026

  9. Filed
  10. Filed
  11. Filed
  12. Filed
  13. Disclosed
    Jonathan Zalevsky · Sale

    Transaction dated Jun 30, 2026

  14. Filed
  15. Disclosed
    Howard W Robin · Sale

    Transaction dated Jun 16, 2026

  16. Disclosed
    Howard W Robin · Sale

    Transaction dated Jun 17, 2026

  17. Disclosed
    Howard W Robin · Sale

    Transaction dated Jun 17, 2026

  18. Disclosed
    Howard W Robin · Sale

    Transaction dated Jun 16, 2026

  19. Disclosed
    Jonathan Zalevsky · Sale

    Transaction dated Jun 15, 2026

  20. Filed
  21. Filed
  22. Record date
    FDA warning letter ↗

    8-K · mentioned before

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on NKTR disclosed in the last 90 days.

See every Congress trade on NKTR →

Company insiders

0 buys · 2 sells · $43.5K sold

  1. ▼ SELLJonathan Zalevsky Chief R&D OfficerNKTR Nektar Therapeutics$13.4Kdisclosed Aug 20 · filed 2 days after the trade
  2. ▼ SELLHoward W Robin President & CEONKTR Nektar Therapeutics$30.1Kdisclosed Aug 20 · filed 2 days after the trade
See every insider trade on NKTR →

Big holders (Schedule 13D / 13G): 2 filings in the last 90 days · newest: Vanguard Capital Management LLC (13G), Jul 31, 2026 ↗

Filings & events

Company filings (8-K) 81

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Other events · item 8.0114
  • Shared information with investors · item 7.0113
  • Quarterly or yearly results · item 2.0211
  • Signed a major agreement · item 1.016
  • Shareholder vote results · item 5.073
  • Directors or officers joined, left or got new pay · item 5.023

Filing red flags 15

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 48

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

2 in the last 90 days · 48 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 10

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 0 filings
  • 13G, just holds: 10 filings

Filed by Vanguard Capital Management LLC · BlackRock, Inc. · Two Seas Capital LP · Fmr LLC

Biggest named funds (13F)

The largest NKTR holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on NKTR

  1. ▼ SELLJonathan Zalevsky Chief R&D OfficerNKTR Nektar Therapeutics$13.4Kdisclosed Aug 20 · filed 2 days after the trade
  2. ▼ SELLHoward W Robin President & CEONKTR Nektar Therapeutics$30.1Kdisclosed Aug 20 · filed 2 days after the trade
  3. ▼ SELLJonathan Zalevsky Chief R&D OfficerNKTR Nektar Therapeutics$398Kdisclosed Jul 2 · filed 2 days after the trade
  4. ▼ SELLHoward W Robin President & CEONKTR Nektar Therapeutics$285Kdisclosed Jun 18 · filed 2 days after the trade
  5. ▼ SELLHoward W Robin President & CEONKTR Nektar Therapeutics$334Kdisclosed Jun 18 · filed 1 day after the trade
  6. ▼ SELLHoward W Robin President & CEONKTR Nektar Therapeutics$277Kdisclosed Jun 18 · filed 1 day after the trade
  7. ▼ SELLHoward W Robin President & CEONKTR Nektar Therapeutics$318Kdisclosed Jun 18 · filed 2 days after the trade
  8. ▼ SELLJonathan Zalevsky Chief R&D OfficerNKTR Nektar Therapeutics$336Kdisclosed Jun 17 · filed 2 days after the trade
See the trades on NKTR in the feed →
People & votes

Which members of Congress traded NKTR, sponsored bills that touch it and voted on them — opens here.